Detalles de la búsqueda
1.
Challenges in foot-and-mouth disease virus strain selection as an input to attain broad vaccine intraserotype cross-protection.
Expert Rev Vaccines
; 20(1): 13-22, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33455492
2.
Mouse model as an efficacy test for foot-and-mouth disease vaccines.
Transbound Emerg Dis
; 67(6): 2507-2520, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32320534
3.
Oral Administration of S-Adenosylmethionine (SAMe) and Lactobacillus Plantarum HEAL9 Improves the Mild-To-Moderate Symptoms of Depression: A Randomized, Double-Blind, Placebo-Controlled Study.
Prim Care Companion CNS Disord
; 22(4)2020 Jun 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32589828
4.
Characterization of a type O foot-and-mouth disease virus re-emerging in the year 2011 in free areas of the Southern Cone of South America and cross-protection studies with the vaccine strain in use in the region.
Vet Microbiol
; 162(2-4): 479-490, 2013 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-23182909
5.
Characterization of foot-and-mouth disease virus from outbreaks in Ecuador during 2009-2010 and cross-protection studies with the vaccine strain in use in the region.
Vaccine
; 29(46): 8230-40, 2011 Oct 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-21911020
6.
Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in Argentina.
Vaccine
; 26(51): 6577-86, 2008 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-18835312
Resultados
1 -
6
de 6
1
Próxima >
>>